Common mistakes around CRP Frauen

Common mistakes around CRP in women: First, CRP is often misinterpreted as a specific infection marker, but it is a non-specific acute-phase reactant. Elevations can stem from inflammation, tissue damage, or hormonal influences such as menstrual cycle phase, pregnancy, or hormone replacement therapy (HRT). Second, a mildly elevated CRP (e.g., 2–5 mg/L) is frequently labeled as pathological, yet it can be physiologically variable in women – especially with oral contraceptive use or during the luteal phase. Third, CRP is often viewed in isolation, ignoring lifestyle confounders like smoking, obesity, or sleep deprivation, which also moderately raise levels. Fourth, the high-sensitivity CRP (hs-CRP) test for cardiovascular risk assessment is misused when applied during acute illness or without stable baseline. Fifth, postmenopausal women naturally have higher CRP, which is not automatically pathological. Key takeaway: a single elevated CRP does not justify a diagnosis; serial measurements and clinical context are essential. Evidence is based on established guidelines and epidemiological studies. Caveat: consumer tests (e.g., MyBody-X) often report a single CRP value without accounting for these confounders – medical interpretation is mandatory.